Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2010-12-14 Regulatory Filings
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2010
Regulatory Filings
2010-12-14 Danish
Governance Information 2010
Governance Information Classification · 95% confidence The document text consists entirely of the bylaws ('Vedtægter') for 'Blue Vision A/S'. It details the company name, purpose, capital structure, authorization for capital increases, rules for general meetings ('Generalforsamlinger'), board structure, management, and signing authority. This content is foundational corporate governance documentation, not a periodic financial filing like an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It also does not fit the definitions for management changes (MANG), director dealings (DIRS), or proxy materials (PSI). Since the provided definitions do not explicitly include 'Bylaws' or 'Articles of Association', the most appropriate fallback category for foundational corporate governance documents that are not explicitly covered elsewhere is 'Governance Information' (CGR), which covers internal rules and board structure.
2010-12-14 English
Regulatory Filings 2010
Regulatory Filings
2010-11-22 Danish
Share Issue/Capital Change 2010
Share Issue/Capital Change Classification · 99% confidence The document is a 'MARKEDSMEDDELELSE' (Company Announcement) from Blue Vision A/S dated November 17, 2010. The content details a significant corporate action: the conditional agreement to acquire a real estate portfolio company ('Target') financed through the issuance of convertible debt instruments. It also discusses necessary steps like capital reduction and the conversion of an existing loan. Crucially, the announcement concludes with an 'Indkaldelse til ekstraordinær generalforsamling' (Invitation to an Extraordinary General Meeting) to approve these actions (capital reduction and authorization to issue convertible debt). Since the document announces a major corporate transaction (M&A/Financing) and calls for a shareholder vote (EGM), it relates to capital structure changes and corporate governance related to financing. The most fitting category among the provided options is 'Capital/Financing Update' (CAP), as the core of the announcement revolves around the acquisition financing structure (convertible debt) and subsequent capital structure adjustments. While it mentions an EGM, the primary driver is the financing/acquisition, not just the voting results (DVA) or general governance (CGR). It is not a full financial report (10-K, IR) or a simple dividend notice (DIV).
2010-11-17 English
Regulatory Filings 2010
Regulatory Filings Classification · 98% confidence The document text is extremely short (77 characters) and consists only of a company announcement header ("Selskabsmeddelelse nr. 24 fra Blue Vision A/S") followed by an instruction to see the attached file ("Se venligst vedhæftet fil."). This perfectly matches the 'MENU VS MEAL' rule, indicating it is an announcement about the publication of a report or filing, rather than the report itself. Since it is a general regulatory announcement in Danish ('Selskabsmeddelelse' translates to Company Announcement) and does not fit a more specific category like DIV, DIRS, or ER, the most appropriate classification is the general regulatory fallback category.
2010-11-17 Danish
Regulatory Filings 2010
Regulatory Filings
2010-08-30 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.